Strumento inattivo

Altre lingue Clovis Oncology, Inc.

Azioni

CLVS.Q

US1894641000

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Clovis Oncology : D.I. 616, 823, 848, 884 - Form 8-K	11/07/23
Clovis Oncology, Inc. Went Out of Business	10/07/23
Clovis Oncology : Modification to Rights of Security Holders - Form 8-K	30/06/23
Revised Third Amened Joint Liquidation Plan Approved for Clovis Oncology, Inc.	16/06/23
Third Amended Joint Liquidation Plan Filed by Clovis Oncology, Inc.	03/06/23
Clovis Oncology : Regulation FD Presentation - Form 8-K	02/06/23
Second Amended Joint Liquidation Plan Filed by Clovis Oncology, Inc.	31/05/23
Clovis Oncology : UNITED STATES BANKRUPTCY COURT - Form 8-K	03/05/23
Zr pharma& GmbH completed the acquisition of certain assets and rights associated with Rubraca from Clovis Oncology, Inc. (OTCPK:CLVS.Q).	01/05/23
US FDA panel backs restricted use of AstraZeneca's prostate cancer drug (April 28)	28/04/23
First Motion for Exclusivity Period Extension Approved For Clovis Oncology, Inc.	28/04/23
Combined Hearing for Disclosure Statement and Plan Approved On Interim Basis for Clovis Oncology, Inc.	21/04/23
First Amended Liquidation Plan and Disclosure Statement Filed by Clovis Oncology, Inc.	19/04/23
Clovis Oncology : Acquisition/Asset Disposal - Form 8-K	14/04/23
Motion for Asset Sale Approved for Clovis Oncology, Inc.	12/04/23
First Motion for Exclusivity Period Extension Filed by Clovis Oncology, Inc.	10/04/23
Zr pharma& GmbH entered into an asset purchase agreement to acquire certain assets and rights associated with Rubraca from Clovis Oncology, Inc. (OTCPK:CLVS.Q) for approximately $140 million.	06/04/23
UK court orders GSK to pay AstraZeneca royalties on total sales of Zejula	05/04/23
Auction Result Filed for Clovis Oncology, Inc.	31/03/23
North American Morning Briefing : Investor Mood -3-	29/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Clovis Oncology, Inc.

Azioni

CLVS.Q

US1894641000

Altre lingue

Filtri